Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights: NVIDIA, UnitedHealth, Bank of America, Exxon Mobil, SAP SE and Sony

Read MoreHide Full Article

For Immediate Release

Chicago, IL – October 19, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: NVIDIA Corporation (NVDA - Free Report) , UnitedHealth Group Inc. (UNH - Free Report) , Bank of America Corporation (BAC - Free Report) , Exxon Mobil Corporation (XOM - Free Report) , SAP SE (SAP - Free Report) and Sony Group Corporation (SONY - Free Report) .

Here are highlights from Monday’s Analyst Blog:

Top Research Reports for NVIDIA, UnitedHealth and Bank of America

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA, UnitedHealth, and Bank of America. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Shares of NVIDIA have outperformed the Zacks General Semiconductor industry in the year to date period (+69.8% vs. +39.5%). The Zacks analyst believes that the company has been benefiting from growth opportunities in ray-traced gaming, rendering, high-performance computing, AI and self-driving cars.

Expansion of NVIDIA GeForce NOW is expected to drive the user base. Solid uptake of artificial intelligence-based smart cockpit infotainment solutions is a boon. Collaboration with Mercedes-Benz is expected to further strengthen NVIDIA’s presence in the autonomous vehicles and other automotive electronics space. The management, however, expects its near-term revenues to be weighed down by the ongoing pandemic.

(You can read the full research report on NVIDIA here >>>)

UnitedHealth shares have gained +33.3% over the past year against the Zacks Medical Insurance industry’s gain of +27.4%. The Zacks analyst believes that UnitedHealth's continued strong growth at Optum as well as UnitedHealthcare segments have been driving revenues. A sturdy balance sheet and solid cash generation abilities not only enable investments but also prudent capital deployment.

UnitedHealth’s international business spans over four of the six largest countries in Latin America, as well as in Europe and over 130 countries around the world. It is one of the few companies in the health insurance space having an expanding overseas business. A decline in memberships in the company’s Commercial business, which constitutes a chunk of its total medical membership, has been hurting revenues though.

(You can read the full research report on UnitedHealth here >>>)

Shares of Bank of America have gained +18.9% over the past six months against the Zacks Major Regional Banks industry’s gain of +12%. The Zacks analyst believes that efforts to improve revenue growth, strong balance sheet and expansion into new markets have been supporting Bank of America.

Opening of new branches, enhancing digital capabilities and initiatives to manage expenses along with a strong balance sheet and liquidity position are other major positives. Lower interest rates and the Federal Reserve’s decision to not change the same in near term are expected to keep hurting the company’s margins and interest income though.

(You can read the full research report on Bank of America here >>>)

Other noteworthy reports we are featuring today include Exxon Mobil, SAP SE and Sony.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                      

https://www.zacks.com                                          

 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.